Pages that link to "Q35675013"

The following pages link to A gene signature for predicting outcome in patients with basal-like breast cancer (Q35675013):

Displaying 29 items.

• Association of Protein Translation and Extracellular Matrix Gene Sets with Breast Cancer Metastasis: Findings Uncovered on Analysis of Multiple Publicly Available Datasets Using Individual Patient Data Approach (Q30000323) (← links)
• A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status (Q33779774) (← links)
• Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response (Q33850657) (← links)
• A program to identify prognostic and predictive gene signatures (Q34105960) (← links)
• Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis (Q34207052) (← links)
• A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy (Q34266467) (← links)
• Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice. (Q34664059) (← links)
• Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K (Q34880928) (← links)
• Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status (Q35124596) (← links)
• Immune cell transcript modules reveal leukocyte heterogeneity in synovial biopsies of seronegative spondylarthropathy patients (Q35531152) (← links)
• The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures (Q36089048) (← links)
• Identification and evaluation of network modules for the prognosis of basal-like breast cancer (Q36232146) (← links)
• Basal-like breast cancer: molecular profiles, clinical features and survival outcomes (Q36325873) (← links)
• Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer. (Q36410466) (← links)
• LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells (Q36723368) (← links)
• A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions (Q37207675) (← links)
• Myosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation (Q37564758) (← links)
• Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer (Q37634494) (← links)
• Breast tumor subgroups reveal diverse clinical prognostic power (Q37736572) (← links)
• Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value. (Q38388111) (← links)
• Dogs as a Model for Cancer. (Q38632844) (← links)
• A cancer stem cell model for studying brain metastases from primary lung cancer (Q39192764) (← links)
• Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma (Q42282780) (← links)
• Increased α-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer. (Q55307144) (← links)
• Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response. (Q55426666) (← links)
• BMI1 is a therapeutic target in recurrent medulloblastoma (Q57805008) (← links)
• Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance (Q58115582) (← links)
• Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer (Q88598928) (← links)
• Roles of Myosin-Mediated Membrane Trafficking in TGF-β Signaling (Q92596369) (← links)